Evaluation of the long-term treatment effects of intravenous idursulfase in patients with mucopolysaccharidosis II (MPS II) using statistical modeling: data from the Hunter Outcome Survey (HOS)

被引：0
|
作者：
Joseph Muenzer
Jaco Botha
Paul Harmatz
Roberto Giugliani
Christoph Kampmann
Barbara K. Burton
机构：
[1] University of North Carolina at Chapel Hill,Department of Genetics
[2] Takeda Pharmaceuticals International AG,undefined
[3] UCSF Benioff Children’s Hospital Oakland,undefined
[4] UFRGS,undefined
[5] Medical Genetics Service,undefined
[6] HCPA,undefined
[7] and INAGEMP,undefined
[8] Johannes Gutenberg University,undefined
[9] Ann & Robert H. Lurie Children’s Hospital of Chicago,undefined
来源：
Orphanet Journal of Rare Diseases | / 16卷
关键词：
Mucopolysaccharidosis II; MPS II; Hunter syndrome; Lysosomal storage disease; Statistical modeling; Disease registry; Idursulfase; Enzyme replacement therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Genotype-phenotype findings in patients with mucopolysaccharidosis II from the Hunter Outcome Survey
    Muenzer, Joseph
    Amartino, Hernan
    Burton, Barbara K.
    Scarpa, Maurizio
    Tylki-Szymanska, Anna
    Audi, Jennifer
    Botha, Jaco
    Fertek, Daniel
    Merberg, David
    Natarajan, Madhusudan
    Whiteman, David A. H.
    Giugliani, Roberto
    MOLECULAR GENETICS AND METABOLISM, 2024, 143 (1-2)
  • [42] Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): Data from the Hunter Outcome Survey
    Mendelsohn, Nancy J.
    Harmatz, Paul
    Bodamer, Olaf
    Burton, Barbara K.
    Giugliani, Roberto
    Jones, Simon A.
    Lampe, Christina
    Malm, Gunilla
    Steiner, Robert D.
    Parini, Rossella
    GENETICS IN MEDICINE, 2010, 12 (12) : 816 - 822
  • [43] Long-term experience with idursulfase beta (Hunterase) in two adolescent patients with MPS II: A case series
    Chan, Mei-Yan
    Nelson, Andrew Jack
    Ngu, Lock-Hock
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2023, 36
  • [44] Long-Term Expression of HMI-203: Investigational Gene Therapy Candidate for Mucopolysaccharidosis Type II (MPS II), or Hunter Syndrome
    Smith, Laura
    Patel, Kruti
    Gingras, Jacinthe
    Tzianabos, Alec
    Schulman, Lindsay
    Zhivich, Victor
    Kivaa, Monicah
    Faulkner, Deiby
    Sengooba, Arnold
    Behmoiras, Liana
    Seabrook, Tania
    Dollive, Serena
    Avila, Nancy
    Zhao, Jingyan
    White, Yvonne
    Newman, Jenn
    Woodcock, Steve
    Smith, Sean
    Francone, Omar
    Seymour, Albert
    MOLECULAR THERAPY, 2021, 29 (04) : 247 - 247
  • [45] Toileting Abilities Survey as a surrogate outcome measure for cognitive function: Findings from neuronopathic mucopolysaccharidosis II patients treated with idursulfase and intrathecal idursulfase
    Hogan, Melissa J.
    Stephens, Kim
    Smith, Erin
    Jalazo, Elizabeth R.
    Hendriksz, Christian J.
    Edwards, Lloyd J.
    Bjoraker, Kendra J.
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2020, 25
  • [46] Long-term open-label phase I/II extension study of intrathecal idursulfase-IT in the treatment of neuronopathic mucopolysaccharidosis II
    Muenzer, Joseph
    Vijayaraghavan, Suresh
    Stein, Margot
    Kearney, Shauna
    Wu, Yuna
    Alexanderian, David
    GENETICS IN MEDICINE, 2022, 24 (07) : 1437 - 1448
  • [47] Clinical characteristics of patients with neuronopathic and non-neuronopathic mucopolysaccharidosis type II: Data from the Hunter Outcome Survey
    Lau, Heather A.
    Harmatz, Paul
    Botha, Jaco
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S91 - S91
  • [48] Enzyme replacement therapy in MPS II patients over 20 years of age or older at treatment initiation: An international case series from the Hunter Outcome Survey (HOS)
    Whiteman, David
    Heiberg, Arvid
    Lampe, Christina
    MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : S98 - S98
  • [49] Age at symptom onset, diagnosis, and enzyme replacement therapy (ERT) initiation among family members with mucopolysaccharidosis II (Hunter Syndrome): Data from the Hunter Outcome Survey (HOS)
    Ficicioglu, Can
    Mendelsohn, Nancy J.
    Giugliani, Roberto
    Lampe, Christina
    Fang, Juanzhi
    MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : S39 - S39
  • [50] Characteristics of patients with mucopolysaccharidosis type II who have received a bone marrow transplant: Data from the Hunter Outcome Survey
    Muenzer, Joseph
    Burton, Barbara K.
    Kampmann, Christoph
    Botha, Jaco
    Jones, Simon A.
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S104 - S104
12345